Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 13 September 1968:
Vol. 161. no. 3846, pp. 1155 - 1157
DOI: 10.1126/science.161.3846.1155

Articles

Allergic Encephalomyelitis: Passive Transfer Prevented by Encephalitogen

Seymour Levine 1, Eugene M. Hoenig 1, and Marian W. Kies 2

1 Pathology Department, New York Medical College Center for Chronic Disease, Bird S. Coler Hospital, Welfare Island, New York
2 National Institute of Mental Health, Bethesda, Maryland 20014

Allergic encephalomyelitis was produced in rats by passive transfer of lymph node cells from donors immunized intradernmally with nleural tissute or an encephalitogenic basic protein pluts adjulvants. The same basic protein, injected intravenously into the recipients before or after transfer of lymph node cells, prevented the disease. Even established lesions were reversed. Inhibition by basic protein was specific for encephalomyelitis; it had no effect onz passive transfer of allergic adrenalitis.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Targeting of Myelin Protein Zero in a Spontaneous Autoimmune Polyneuropathy.
H.-J. Kim, C.-G. Jung, M. A. Jensen, D. Dukala, and B. Soliven (2008)
J. Immunol. 181, 8753-8760
   Abstract »    Full Text »    PDF »
Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis.
F. Odoardi, N. Kawakami, Z. Li, C. Cordiglieri, K. Streyl, M. Nosov, W. E. F. Klinkert, J. W. Ellwart, J. Bauer, H. Lassmann, et al. (2007)
PNAS 104, 920-925
   Abstract »    Full Text »    PDF »
Materials and Methods.
(1999)
Multiple Sclerosis 5, 003-9
   PDF »
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.
J. Critchfield, M. Racke, J. Zuniga-Pflucker, B Cannella, C. Raine, J Goverman, and M. Lenardo (1994)
Science 263, 1139-1143
   Abstract »    PDF »
Allergic Encephalomyelitis: New Form Featuring Polymorphonuclear Leukocytes.
S. Levine and R. Sowinski (1971)
Science 171, 498-499
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)